Home Details
| Official Symbol of Gene | PDCD1 |
| Species | Homo sapiens |
| Entrez Gene ID | 5133 |
| Official Full Name | programmed cell death 1 |
| Also known as | PD1; PD-1; CD279; SLEB2; hPD-1; hPD-l; hSLE1 |
| Gene Type | protein coding |
| dbXrefs | Ensembl:ENSG00000188389 MIM:600244; AllianceGenome:HGNC:8760 |
| Map Location | 2q37.3 |
| Variation Type | intronic polymorphism |
| refSNP ID | 7146G/A |
| Detected Sample | peripheral blood |
| Sample Detail | PBMC |
| Detected Method | PCR |
| Disease | MS |
| Disease subtype | RRã€PP |
| Population | Germany |
| Sample Size | 939 German MS patients,566 patients [60%] with relapsing-remitting MS, 279 (30%) with secondary, and 94 (10%) with primary progressive MS) and 272 healthy white controls |
| Pubmed ID | 15912506 |
| Year | 2005 |
| Title | A PD-1 Polymorphism Is Associated with Disease Progression in Multiple Sclerosis |
| Risk Type | Disease risk |
| Main Result | positive |
| Result | Importantly, PD-1–mediated inhibition of T-cell cytokine secretion (interferon-) is impaired in patients carrying the PD-1 polymorphism. In conclusion, our data suggest that PD-1 polymorphism is a genetic modifier of the progression of MS, possibly through inducing a partial defect in PD-1–mediated inhibition of T-cell activation. |
| Mechanism/Pathway | a genetic modifier of the progression of MS |

2023,CopyRight © HMU. College of Bioinformatics Science and Technology, Harbin, China.